{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T17:08:29Z","timestamp":1793207309656,"version":"4.5.0"},"reference-count":80,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T00:00:00Z","timestamp":1594598400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007949","name":"Reumatikerf\u00f6rbundet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007949","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003252","name":"Lunds Universitet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003252","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.semarthrit.2020.07.005","type":"journal-article","created":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T21:49:38Z","timestamp":1594676978000},"page":"1040-1048","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":140,"title":["Incidence and prevalence of giant cell arteritis and polymyalgia rheumatica: A systematic literature review"],"prefix":"10.1016","volume":"50","author":[{"given":"Ankita","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aladdin J.","family":"Mohammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Turesson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.semarthrit.2020.07.005_bib0001","first-page":"1739","article-title":"The incidence of polymyalgia rheumatica and temporal arteritis in the county of Aust Agder, south Norway: a prospective study 1987-94","volume":"24","author":"Gran","year":"1997","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2020.07.005_bib0002","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3899\/jrheum.160249","article-title":"Rate of comorbidities in giant cell arteritis: a population-based study","volume":"44","author":"Mohammad","year":"2017","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2020.07.005_bib0003","first-page":"S15","article-title":"The incidence of giant cell arteritis in Jerusalem over a 25-year period: annual and seasonal fluctuations","volume":"25","author":"Bas-Lando","year":"2007","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"10.1016\/j.semarthrit.2020.07.005_bib0004","first-page":"351","article-title":"High incidence of polymyalgia rheumatica and giant cell arteritis in a Swedish community","volume":"9","author":"Noltorp","year":"1991","journal-title":"Clin Exp Rheumatol"},{"issue":"21","key":"10.1016\/j.semarthrit.2020.07.005_bib0005","first-page":"376","article-title":"The diagnosis and treatment of giant cell arteritis","volume":"110","author":"Ness","year":"2013","journal-title":"Dtsch Arztebl Int"},{"issue":"2","key":"10.1016\/j.semarthrit.2020.07.005_bib0006","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/art.20227","article-title":"Reappraisal of the epidemiology of giant cell arteritis in Olmsted County, Minnesota, over a fifty-year period","volume":"51","author":"Salvarani","year":"2004","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"6","key":"10.1016\/j.semarthrit.2020.07.005_bib0007","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1136\/annrheumdis-2013-204652","article-title":"Incidence and mortality rates of biopsy-proven giant cell arteritis in southern Sweden","volume":"74","author":"Mohammad","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.semarthrit.2020.07.005_bib0008","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/rheumatology\/keg116","article-title":"Giant cell arteritis: epidemiological clues to its pathogenesis and an update on its treatment","volume":"42","author":"Nordborg","year":"2003","journal-title":"Rheumatology"},{"issue":"2","key":"10.1016\/j.semarthrit.2020.07.005_bib0009","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/md.0b013e31803d1764","article-title":"Giant cell arteritis in northwestern Spain: a 25-year epidemiologic study","volume":"86","author":"Gonzalez-Gay","year":"2007","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"10.1016\/j.semarthrit.2020.07.005_bib0010","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1136\/bjo.2006.108845","article-title":"Epidemiology of giant-cell arteritis in an Arab population: a 22-year study","volume":"91","author":"Chaudhry","year":"2007","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"10.1016\/j.semarthrit.2020.07.005_bib0011","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1002\/art.11195","article-title":"Clinical and epidemiologic analysis of giant cell (temporal) arteritis from a nationwide survey in 1998 in Japan: the first government-supported nationwide survey","volume":"49","author":"Kobayashi","year":"2003","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"8","key":"10.1016\/j.semarthrit.2020.07.005_bib0012","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/acr.23132","article-title":"Epidemiology of polymyalgia rheumatica 2000-2014 and examination of incidence and survival trends over 45 years: a population-based study","volume":"69","author":"Raheel","year":"2017","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"22","key":"10.1016\/j.semarthrit.2020.07.005_bib0013","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1001\/jama.2016.5444","article-title":"Polymyalgia rheumatica and giant cell arteritis: a systematic review","volume":"315","author":"Buttgereit","year":"2016","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.semarthrit.2020.07.005_bib0014","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1136\/annrheumdis-2018-213883","article-title":"Incidence, prevalence and treatment burden of polymyalgia rheumatica in the UK over two decades: a population-based study","volume":"77","author":"Partington","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.semarthrit.2020.07.005_bib0015","first-page":"1694","article-title":"Trends in the incidence of polymyalgia rheumatica over a 30 year period in Olmsted County, Minnesota, USA","volume":"29","author":"Doran","year":"2002","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2020.07.005_bib0016","first-page":"273","article-title":"Giant cell arteritis and polymyalgia rheumatica in a region of Finland: an epidemiologic, clinical and pathologic study, 1984-1988","volume":"19","author":"Franz\u00e9n","year":"1992","journal-title":"J Rheumatol"},{"issue":"9860","key":"10.1016\/j.semarthrit.2020.07.005_bib0017","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0140-6736(12)60680-1","article-title":"Polymyalgia rheumatica","volume":"381","author":"Kermani","year":"2013","journal-title":"Lancet North Am Ed"},{"issue":"3","key":"10.1016\/j.semarthrit.2020.07.005_bib0018","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/art.1780380311","article-title":"Epidemiology of polymyalgia rheumatica in olmsted county, minnesota, 1970\u20131991","volume":"38","author":"Salvarani","year":"1995","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.semarthrit.2020.07.005_bib0019","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.semarthrit.2017.04.001","article-title":"Contemporary prevalence estimates for giant cell arteritis and polymyalgia rheumatica, 2015","volume":"47","author":"Crowson","year":"2017","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2020.07.005_bib0020","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/574248","article-title":"Giant cell arteritis: a systematic review of the qualitative and semiquantitative methods to assess vasculitis with 18F-fluorodeoxyglucose positron emission tomography","volume":"2014","author":"Puppo","year":"2014","journal-title":"Biomed Res Int"},{"issue":"3","key":"10.1016\/j.semarthrit.2020.07.005_bib0021","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/rheumatology\/keu331","article-title":"Body mass index and the risk of giant cell arteritis: results from a prospective study","volume":"54","author":"Jakobsson","year":"2015","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"10.1016\/j.semarthrit.2020.07.005_bib0022","first-page":"92","article-title":"Incidence and prevalence of polymyalgia rheumatica (PMR): the importance of the epidemiological context. the Italian case","volume":"7","author":"Manzo","year":"2019","journal-title":"Med Sci (Basel)."},{"issue":"10","key":"10.1016\/j.semarthrit.2020.07.005_bib0023","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1002\/art.24459","article-title":"Epidemiology of giant cell arteritis and polymyalgia rheumatica","volume":"61","author":"Gonzalez-Gay","year":"2009","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"3","key":"10.1016\/j.semarthrit.2020.07.005_bib0024","doi-asserted-by":"crossref","first-page":"192","DOI":"10.7326\/0003-4819-123-3-199508010-00006","article-title":"The incidence of giant cell arteritis in Olmsted County, Minnesota: apparent fluctuations in a cyclic pattern","volume":"123","author":"Salvarani","year":"1995","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.semarthrit.2020.07.005_bib0025","doi-asserted-by":"crossref","first-page":"162","DOI":"10.7326\/0003-4819-88-2-162","article-title":"Temporal arteritis: a 25-year epidemiologic, clinical, and pathologic study","volume":"88","author":"Huston","year":"1978","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.semarthrit.2020.07.005_bib0026","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1002\/art.1780310607","article-title":"Trends in incidence and clinical presentation of temporal arteritis in Olmsted County, Minnesota, 1950\u20131985","volume":"31","author":"Machado","year":"1988","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.semarthrit.2020.07.005_bib0027","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3109\/03009742.2014.982701","article-title":"The incidence of giant cell arteritis in Olmsted County, Minnesota, over a 60-year period 1950-2009","volume":"44","author":"Chandran","year":"2015","journal-title":"Scand J Rheumatol"},{"issue":"5","key":"10.1016\/j.semarthrit.2020.07.005_bib0028","doi-asserted-by":"crossref","first-page":"672","DOI":"10.7326\/0003-4819-97-5-672","article-title":"Polymyalgia rheumatica: a 10-year epidemiologic and clinical study","volume":"97","author":"Chuang","year":"1982","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.semarthrit.2020.07.005_bib0029","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/art.1780340313","article-title":"Epidemiologic and immunogenetic aspects of polymyalgia rheumatica and giant cell arteritis in northern Italy","volume":"34","author":"Salvarani","year":"1991","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.semarthrit.2020.07.005_bib0030","first-page":"205","article-title":"Polymyalgia rheumatica and giant cell arteritis: a 5-year epidemiologic and clinical study in Reggio Emilia, Italy","volume":"5","author":"Salvarani","year":"1987","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2020.07.005_bib0031","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/s13075-017-1479-6","article-title":"Incidence of giant cell arteritis in Western Norway 1972\u20132012: a retrospective cohort study","volume":"19","author":"Brekke","year":"2017","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"10.1016\/j.semarthrit.2020.07.005_bib0032","doi-asserted-by":"crossref","first-page":"297","DOI":"10.4078\/jrd.2014.21.6.297","article-title":"Epidemiology of polymyalgia rheumatica in Korea","volume":"21","author":"Kim","year":"2014","journal-title":"J Rheum Dis"},{"key":"10.1016\/j.semarthrit.2020.07.005_bib0033","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1186\/s12891-016-1127-3","article-title":"The prevalence of giant cell arteritis and polymyalgia rheumatica in a UK primary care population","volume":"17","author":"Yates","year":"2016","journal-title":"BMC Musculoskelet Disord"},{"issue":"2","key":"10.1016\/j.semarthrit.2020.07.005_bib0034","first-page":"033 p","article-title":"Validity of polymyalgia rheumatica diagnoses and classification criteria in primary health care","volume":"3","author":"Fors","year":"2019","journal-title":"Rheumatol Adv Pract [Internet]"},{"issue":"8","key":"10.1016\/j.semarthrit.2020.07.005_bib0035","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1136\/ard.2005.046912","article-title":"Incidence of diagnosed polymyalgia rheumatica and temporal arteritis in the United Kingdom, 1990-2001","volume":"65","author":"Smeeth","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2020.07.005_bib0036","article-title":"A new era for giant cell arteritis","author":"Lyons","year":"2019","journal-title":"Eye"},{"issue":"4","key":"10.1016\/j.semarthrit.2020.07.005_bib0037","first-page":"506","article-title":"The spectrum of giant cell arteritis and polymyalgia rheumatica: revisiting the concept of the disease","volume":"56","author":"Dejaco","year":"2016","journal-title":"Rheumatology"},{"issue":"5","key":"10.1016\/j.semarthrit.2020.07.005_bib0038","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1136\/annrheumdis-2017-212649","article-title":"EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice","volume":"77","author":"Dejaco","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.semarthrit.2020.07.005_bib0039","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1056\/NEJMoa1613849","article-title":"Trial of tocilizumab in giant-cell arteritis","volume":"377","author":"Stone","year":"2017","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.semarthrit.2020.07.005_bib0040","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1080\/03009742.2019.1571223","article-title":"Swedish Society of Rheumatology 2018 guidelines for investigation, treatment, and follow-up of giant cell arteritis","volume":"48","author":"Turesson","year":"2019","journal-title":"Scand J Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2020.07.005_bib0041","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/annrheumdis-2019-215672","article-title":"Update of the EULAR recommendations for the management of large vessel vasculitis","volume":"79","author":"Hellmich","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.semarthrit.2020.07.005_bib0042","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.bbmt.2017.10.010","article-title":"A European HLA isolate and its implications for hematopoietic stem cell transplant donor procurement","volume":"24","author":"Linjama","year":"2018","journal-title":"Biol Blood Marrow Transpl"},{"issue":"1","key":"10.1016\/j.semarthrit.2020.07.005_bib0043","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s13075-015-0692-4","article-title":"Association of HLA-DRB1 amino acid residues with giant cell arteritis: genetic association study, meta-analysis and geo-epidemiological investigation","volume":"17","author":"Mackie","year":"2015","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"10.1016\/j.semarthrit.2020.07.005_bib0044","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1080\/03009742.2018.1506821","article-title":"Cardiovascular risk factors and incident giant cell arteritis: a population-based cohort study","volume":"48","author":"Tomasson","year":"2019","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.semarthrit.2020.07.005_bib0045","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/keaa080","article-title":"Negative associations for fasting blood glucose, cholesterol and triglyceride levels with the development of giant cell arteritis","author":"Wadstr\u00f6m","year":"2020","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.semarthrit.2020.07.005_bib0046","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.semarthrit.2003.12.001","article-title":"HLA-DRB1 allele distribution in polymyalgia rheumatica and giant cell arteritis: Influence on clinical subgroups and prognosis","volume":"34","author":"Mart\u0131\u0301nez-Taboda","year":"2004","journal-title":"Semin Arthritis Rheum"},{"issue":"s10","key":"10.1016\/j.semarthrit.2020.07.005_bib0047","article-title":"Giant cell arteritis in India\u2013Report from a tertiary care center along with total published experience from India","volume":"9","author":"Sharma","year":"2014","journal-title":"Indian J Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2020.07.005_bib0048","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1080\/00325481.2018.1399774","article-title":"Incidence of rheumatoid arthritis, psoriatic arthritis and polymyalgia rheumatica in an inland area of central Italy: results of the CAMPO-RHE study","volume":"130","author":"De Socio","year":"2018","journal-title":"Postgrad Med"},{"issue":"4","key":"10.1016\/j.semarthrit.2020.07.005_bib0049","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1136\/annrheumdis-2011-200329","article-title":"provisional classification criteria for polymyalgia rheumatica: a European League against rheumatism\/American College of Rheumatology collaborative initiative","volume":"71","author":"Dasgupta","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.semarthrit.2020.07.005_bib0050","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s00296-016-3474-7","article-title":"Estimating the incidence of connective tissue diseases and vasculitides in a defined population in Northern Savo area in 2010","volume":"36","author":"Elfving","year":"2016","journal-title":"Rheumatol Int"},{"issue":"3","key":"10.1016\/j.semarthrit.2020.07.005_bib0051","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/acr.22429","article-title":"Incidence of giant cell arteritis and characteristics of patients: data-driven analysis of comorbidities","volume":"67","author":"Petri","year":"2015","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"11","key":"10.1016\/j.semarthrit.2020.07.005_bib0052","first-page":"2624","article-title":"Temporal arteritis in Vest Agder County in southern Norway: incidence and clinical findings","volume":"27","author":"Haugeberg","year":"2000","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2020.07.005_bib0053","first-page":"112","article-title":"Synchronous variations of the incidence of temporal arteritis and polymyalgia rheumatica in different regions of Denmark; association with epidemics of Mycoplasma pneumoniae infection","volume":"23","author":"Elling","year":"1996","journal-title":"J Rheumatol"},{"issue":"7","key":"10.1016\/j.semarthrit.2020.07.005_bib0054","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/art.1780370705","article-title":"Giant cell arteritis in Iceland","volume":"37","author":"Baldursson","year":"1994","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.semarthrit.2020.07.005_bib0055","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3109\/03009749309095141","article-title":"Incidence and survival rate in cases of biopsy-proven temporal arteritis","volume":"22","author":"Rajala","year":"1993","journal-title":"Scand J Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2020.07.005_bib0056","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/rheumatology\/kez251","article-title":"Characteristics and management of giant cell arteritis in France: a study based on national health insurance claims data","volume":"59","author":"Mahr","year":"2019","journal-title":"Rheumatology"},{"issue":"2","key":"10.1016\/j.semarthrit.2020.07.005_bib0057","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s10067-018-4236-6","article-title":"The incidence of giant cell arteritis in Slovenia","volume":"38","author":"Pucelj","year":"2019","journal-title":"Clin Rheumatol"},{"issue":"3","key":"10.1016\/j.semarthrit.2020.07.005_bib0058","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/acr.22942","article-title":"Incidence, prevalence, and survival of biopsy-proven giant cell arteritis in Northern Italy during a 26-year period","volume":"69","author":"Catanoso","year":"2017","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"2 Suppl 89","key":"10.1016\/j.semarthrit.2020.07.005_bib0059","first-page":"S-11-8","article-title":"Epidemiological study of primary systemic vasculitides among adults in southern Spain and review of the main epidemiological studies","volume":"33","author":"Romero-G\u00f3mez","year":"2015","journal-title":"Clin Exp Rheumatol"},{"issue":"27(5","key":"10.1016\/j.semarthrit.2020.07.005_bib0060","first-page":"830","article-title":"Giant cell arteritis and polymyalgia rheumatica in northwestern Turkey: clinical features and epidemiological data","volume":"27","author":"Pamuk ON","year":"2009","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"10.1016\/j.semarthrit.2020.07.005_bib0061","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0889-857X(05)70232-5","article-title":"Epidemiology of the vasculitides","volume":"27","author":"Gonz\u00e1lez-Gay","year":"2001","journal-title":"Rheum Dis Clin North Am"},{"issue":"5","key":"10.1016\/j.semarthrit.2020.07.005_bib0062","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/00005792-199909000-00002","article-title":"Systemic vasculitis in adults in northwestern Spain, 1988-1997. Clinical and epidemiologic aspects","volume":"78","author":"Gonz\u00e1lez-Gay","year":"1999","journal-title":"Medicine."},{"issue":"11","key":"10.1016\/j.semarthrit.2020.07.005_bib0063","first-page":"2166","article-title":"Giant cell arteritis in Lugo, Spain: a more frequent disease with fewer classic features","volume":"24","author":"Gonz\u00e1lez-Gay","year":"1997","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2020.07.005_bib0064","first-page":"277","article-title":"Temporal arteritis in a northwestern area of Spain: study of 57 biopsy proven patients","volume":"19","author":"Gonz\u00e1lez-Gay","year":"1992","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2020.07.005_bib0065","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jcjo.2018.03.002","article-title":"The incidence of giant cell arteritis in Ontario, Canada","volume":"54","author":"Ing","year":"2019","journal-title":"Can J Ophthalmol"},{"issue":"1","key":"10.1016\/j.semarthrit.2020.07.005_bib0066","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3129\/i08-164","article-title":"Giant cell arteritis in Alaska Natives","volume":"44","author":"Mader","year":"2009","journal-title":"Can J Ophthalmol"},{"issue":"10","key":"10.1016\/j.semarthrit.2020.07.005_bib0067","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1002\/art.1780261007","article-title":"The epidemiology of giant cell arteritis. Report of a ten-year study in Shelby County, Tennessee","volume":"26","author":"Smith","year":"1983","journal-title":"Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.semarthrit.2020.07.005_bib0068","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.3899\/jrheum.150557","article-title":"The incidence of primary systemic vasculitis in Jerusalem: a 20-year hospital-based retrospective study","volume":"43","author":"Nesher","year":"2016","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2020.07.005_bib0069","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/imj.12293","article-title":"Epidemiology of biopsy-proven giant cell arteritis in South Australia","volume":"44","author":"Dunstan","year":"2014","journal-title":"Intern Med J"},{"issue":"1329","key":"10.1016\/j.semarthrit.2020.07.005_bib0070","first-page":"44","article-title":"The epidemiology of giant cell arteritis in Otago, New Zealand: a 9-year analysis","volume":"124","author":"Abdul-Rahman","year":"2011","journal-title":"N Z Med J"},{"issue":"1 Suppl 44","key":"10.1016\/j.semarthrit.2020.07.005_bib0071","first-page":"S15","article-title":"The incidence of giant cell arteritis in Jerusalem over a 25-year period: annual and seasonal fluctuations","author":"Bas-Lando M","year":"2007","journal-title":"Clin Exp Rheumatol"},{"issue":"10","key":"10.1016\/j.semarthrit.2020.07.005_bib0072","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1093\/rheumatology\/33.10.938","article-title":"Giant cell arteritis in Jerusalem: a 12-year epidemiological study","volume":"33","author":"Sonnenblick","year":"1994","journal-title":"Rheumatology"},{"issue":"2","key":"10.1016\/j.semarthrit.2020.07.005_bib0073","first-page":"241","article-title":"Epidemiology of temporal arteritis in Israel","volume":"18","author":"Friedman","year":"1982","journal-title":"Isr J Med Sci"},{"issue":"3","key":"10.1016\/j.semarthrit.2020.07.005_bib0074","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3899\/jrheum.180714","article-title":"Increased incidence of giant cell arteritis in urban areas?","volume":"46","author":"Brekke","year":"2019","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.semarthrit.2020.07.005_bib0075","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/rheumatology\/34.3.261","article-title":"Epidemiology and mortality in 220 patients with polymyalgia rheumatica","volume":"34","author":"Schaufelberger","year":"1995","journal-title":"Rheumatology"},{"issue":"5","key":"10.1016\/j.semarthrit.2020.07.005_bib0076","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1093\/rheumatology\/ket440","article-title":"Doubled prevalence rates of ANCA-associated vasculitides and giant cell arteritis between 1994 and 2006 in northern Germany","volume":"53","author":"Herlyn","year":"2014","journal-title":"Rheumatology"},{"issue":"12","key":"10.1016\/j.semarthrit.2020.07.005_bib0077","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1093\/rheumatology\/39.12.1396","article-title":"Giant cell arteritis is more prevalent in urban than in rural populations: results of an epidemiological study of primary systemic vasculitides in Germany","volume":"39","author":"Reinhold\u2010Keller","year":"2000","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.semarthrit.2020.07.005_bib0078","doi-asserted-by":"crossref","first-page":"e000166","DOI":"10.1136\/rmdopen-2015-000166","article-title":"Prevalence of rheumatic and musculoskeletal diseases and their impact on health-related quality of life, physical function and mental health in Portugal: results from EpiReumaPt- a national health survey","volume":"2","author":"Branco","year":"2016","journal-title":"RMD Open"},{"issue":"9","key":"10.1016\/j.semarthrit.2020.07.005_bib0079","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1002\/art.24793","article-title":"Polymyalgia rheumatica prevalence in a population-based sample","volume":"61","author":"Bernatsky","year":"2009","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"9","key":"10.1016\/j.semarthrit.2020.07.005_bib0080","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1007\/s00296-019-04387-5","article-title":"Prevalence of polymyalgia rheumatica in Colombia: data from the national health registry 2012\u20132016","volume":"39","author":"Fern\u00e1ndez-\u00c1vila","year":"2019","journal-title":"Rheumatol Int"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017220302043?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017220302043?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:05:27Z","timestamp":1758733527000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017220302043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":80,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S0049017220302043"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2020.07.005","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence and prevalence of giant cell arteritis and polymyalgia rheumatica: A systematic literature review","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2020.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}